(Q34573314)

English

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

1 reference

Europe PubMed Central

GnRH-antagonists in ovarian stimulation for IVF in patients with poor response to gonadotrophins, polycystic ovary syndrome, and risk of ovarian hyperstimulation: a meta-analysis (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

0 references

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

author name string

G Griesinger

1

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

K Diedrich

2

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

B C Tarlatzis

3

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

E M Kolibianakis

4

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Reproductive BioMedicine Online

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

628-638

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Use of GnRHa to induce ovulation in GnRH antagonist cycles

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of agonistic flare-up-protocol and antagonistic multiple dose protocol in ovarian stimulation of poor responders: results of a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH antagonist in assisted reproduction: a Cochrane review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Serum inhibin A, VEGF and TNFalpha levels after triggering oocyte maturation with GnRH agonist compared with HCG in women with polycystic ovaries undergoing IVF treatment: a prospective randomized trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH antagonist versus long GnRH agonist protocol in poor responders undergoing IVF: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Will GnRH antagonists provide new hope for patients considered 'difficult responders' to GnRH agonist protocols?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadotropin-releasing hormone (GnRH) antagonist plus recombinant luteinizing hormone vs. a standard GnRH agonist short protocol in patients at risk for poor ovarian response.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Suppression of the endogenous luteinizing hormone surge by the gonadotrophin-releasing hormone antagonist Cetrorelix during ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH agonists and antagonists in assisted reproduction: pregnancy rate.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Why is the clinical acceptance of gonadotropin-releasing hormone antagonist cotreatment during ovarian hyperstimulation for in vitro fertilization so slow?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Gonadotrophin-releasing hormone antagonists: will they replace the agonists?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian hyperstimulation syndrome: an update review.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians' second choice? Data from the German national IVF registry

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized comparison of two ovarian stimulation protocols with gonadotropin-releasing hormone (GnRH) antagonist cotreatment for in vitro fertilization commencing recombinant follicle-stimulating hormone on cycle day 2 or 5 with the standard long

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian stimulation by concomitant administration of cetrorelix acetate and HMG following Diane-35 pre-treatment for patients with polycystic ovary syndrome: a prospective randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Use of a single bolus of GnRH agonist triptorelin to trigger ovulation after GnRH antagonist ganirelix treatment in women undergoing ovarian stimulation for assisted reproduction, with special reference to the prevention of ovarian hyperstimulation

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Prediction of ovarian hyperstimulation syndrome: why predict if we can prevent!

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Severe OHSS: yes, there is a strategy to prevent it!

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Recombinant gonadotrophin-based, ovarian hyperstimulation syndrome-free stimulation of the high responder: suggested protocol for further research

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Among patients treated for IVF with gonadotrophins and GnRH analogues, is the probability of live birth dependent on the type of analogue used? A systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A lower ongoing pregnancy rate can be expected when GnRH agonist is used for triggering final oocyte maturation instead of HCG in patients undergoing IVF with GnRH antagonists

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Reproductive outcome of polycystic ovarian syndrome patients treated with GnRH antagonists and recombinant FSH for IVF/ICSI.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Tailoring the GnRH antagonist cetrorelix acetate to individual patients' needs in ovarian stimulation for IVF: results of a prospective, randomized study

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of a gonadotropin-releasing hormone (GnRH) antagonist and GnRH agonist flare-up regimen in poor responders undergoing ovarian stimulation.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH antagonist in IVF poor-responder patients: results of a randomized trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Lower levels of inhibin A and pro-alphaC during the luteal phase after triggering oocyte maturation with a gonadotropin-releasing hormone agonist versus human chorionic gonadotropin

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Can we eliminate severe ovarian hyperstimulation syndrome?

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

A randomized prospective study of microdose leuprolide versus ganirelix in in vitro fertilization cycles for poor responders

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

GnRH antagonists in ovarian stimulation for IVF.

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical management of low ovarian response to stimulation for IVF: a systematic review

1 reference

https://api.crossref.org/works/10.1016%2FS1472-6483%2810%2960652-9

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1472-6483(10)60652-9

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34573314&oldid=1588317618"